R&R Inc.
Records under this name other than patents R&R Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,198,329 | Memory consolidation promoting agent and method of use Formerly held Lapsed on the fee record Ended Jun 12, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2020 | From the USPTO record |
| US 8,030,360 | Anti-wrinkle agent Formerly held Lapsed on the fee record Ended Oct 4, 2019 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2019 | From the USPTO record |
| US 7,045,516 | Benzoxazole derivatives and drugs containing the same as the active ingredient Formerly held Lapsed on the fee record Ended May 16, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 16, 2018 | From the USPTO record |
| US 6,037,342 | Serotonin 5-HT.sub.3 receptor partial activator Formerly held Term ended Term ended May 6, 2017 · From the USPTO record | Term ended | Term ended May 6, 2017 | From the USPTO record |
| US 6,867,226 | Serotonin 5-HT3 receptor partial activator Formerly held Lapsed on the fee record Ended Mar 15, 2017 · From the USPTO record | Lapsed on the fee record | Ended Mar 15, 2017 | From the USPTO record |
| US 8,168,677 | Method for treatment of inflammatory bowel disease Formerly held Lapsed on the fee record Ended May 1, 2016 · From the USPTO record | Lapsed on the fee record | Ended May 1, 2016 | From the USPTO record |
| US 7,968,600 | Medicament for preventive and therapeutic treatment of physical dysfunction caused by nerve damage Formerly held Lapsed on the fee record Ended Jun 28, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jun 28, 2015 | From the USPTO record |
| US 6,552,057 | Serotonin 5-HT3 receptor partial activator Formerly held Lapsed on the fee record Ended Apr 22, 2015 · From the USPTO record | Lapsed on the fee record | Ended Apr 22, 2015 | From the USPTO record |
| US 6,537,237 | Orthotic device Lapsed on the fee record Ended Mar 25, 2015 · From the USPTO record | Lapsed on the fee record | Ended Mar 25, 2015 | From the USPTO record |
| US 7,902,260 | Medicament for preventive and/or therapeutic treatment of lower urinary tract symptom Formerly held Lapsed on the fee record Ended Mar 8, 2015 · From the USPTO record | Lapsed on the fee record | Ended Mar 8, 2015 | From the USPTO record |